Found: 39
Select item for more details and to access through your institution.
Sensitivity of neuroblastoma to the novel kinase inhibitor cabozantinib is mediated by ERK inhibition.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Mechanisms of Efficacy of the FGFR1–3 Inhibitor AZD4547 in Pediatric Solid Tumor Models.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 6, p. 1677, doi. 10.1007/s10637-020-00933-2
- By:
- Publication type:
- Article
The novel kinase inhibitor ponatinib is an effective anti-angiogenic agent against neuroblastoma.
- Published in:
- Investigational New Drugs, 2016, v. 34, n. 6, p. 685, doi. 10.1007/s10637-016-0387-y
- By:
- Publication type:
- Article
The novel kinase inhibitor EMD1214063 is effective against neuroblastoma.
- Published in:
- Investigational New Drugs, 2014, v. 32, n. 5, p. 815, doi. 10.1007/s10637-014-0107-4
- By:
- Publication type:
- Article
The combination of the novel glycolysis inhibitor 3-BrOP and rapamycin is effective against neuroblastoma.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 1, p. 191, doi. 10.1007/s10637-010-9551-y
- By:
- Publication type:
- Article
CD114: A New Member of the Neural Crest-Derived Cancer Stem Cell Marker Family.
- Published in:
- Journal of Cellular Biochemistry, 2017, v. 118, n. 2, p. 221, doi. 10.1002/jcb.25656
- By:
- Publication type:
- Article
Identification of a novel gene signature for neuroblastoma differentiation using a Boolean implication network.
- Published in:
- Genes, Chromosomes & Cancer, 2023, v. 62, n. 6, p. 313, doi. 10.1002/gcc.23124
- By:
- Publication type:
- Article
SPARC expression is associated with impaired tumor growth, inhibited angiogenesis and changes in the extracellular matrix.
- Published in:
- International Journal of Cancer, 2006, v. 118, n. 2, p. 310, doi. 10.1002/ijc.21357
- By:
- Publication type:
- Article
UBE4B interacts with the ITCH E3 ubiquitin ligase to induce Ku70 and c-FLIPL polyubiquitination and enhanced neuroblastoma apoptosis.
- Published in:
- Cell Death & Disease, 2023, v. 14, n. 11, p. 1, doi. 10.1038/s41419-023-06252-7
- By:
- Publication type:
- Article
Maintenance DFMO Increases Survival in High Risk Neuroblastoma.
- Published in:
- Scientific Reports, 2018, v. 8, n. 1, p. 1, doi. 10.1038/s41598-018-32659-w
- By:
- Publication type:
- Article
USP7 Inhibition Suppresses Neuroblastoma Growth via Induction of p53-Mediated Apoptosis and EZH2 and N-Myc Downregulation.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 18, p. 13780, doi. 10.3390/ijms241813780
- By:
- Publication type:
- Article
The Anti-Tumor Activity of the NEDD8 Inhibitor Pevonedistat in Neuroblastoma.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 12, p. 6565, doi. 10.3390/ijms22126565
- By:
- Publication type:
- Article
The Potential Functional Roles of NME1 Histidine Kinase Activity in Neuroblastoma Pathogenesis.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 9, p. 3319, doi. 10.3390/ijms21093319
- By:
- Publication type:
- Article
Regorafenib is effective against neuroblastoma in vitro and in vivo and inhibits the RAS/MAPK, PI3K/Akt/mTOR and Fos/Jun pathways.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Validation of a prognostic multi-gene signature in high-risk neuroblastoma using the high throughput digital NanoString nCounter™ system.
- Published in:
- Molecular Oncology, 2014, v. 8, n. 3, p. 669, doi. 10.1016/j.molonc.2014.01.010
- By:
- Publication type:
- Article
Gonadotropin-Dependent Precocious Puberty: Neoplastic Causes and Endocrine Considerations.
- Published in:
- International Journal of Pediatric Endocrinology, 2011, p. 1, doi. 10.1155/2010/184502
- By:
- Publication type:
- Article
Is high-risk neuroblastoma induction chemotherapy possible without G-CSF? A pilot study of safety and treatment delays in the absence of primary prophylactic hematopoietic growth factors.
- Published in:
- 2020
- By:
- Publication type:
- journal article
New aspects of neuroblastoma treatment: ASPHO 2011 symposium review.
- Published in:
- Pediatric Blood & Cancer, 2012, v. 58, n. 7, p. 1099, doi. 10.1002/pbc.24116
- By:
- Publication type:
- Article
Notch pathway activation induces neuroblastoma tumor cell growth arrest.
- Published in:
- Pediatric Blood & Cancer, 2012, v. 58, n. 5, p. 682, doi. 10.1002/pbc.23202
- By:
- Publication type:
- Article
Nifurtimox Is Effective Against Neural Tumor Cells and Is Synergistic with Buthionine Sulfoximine.
- Published in:
- Scientific Reports, 2016, p. 27458, doi. 10.1038/srep27458
- By:
- Publication type:
- Article
UBE4B levels are correlated with clinical outcomes in neuroblastoma patients and with altered neuroblastoma cell proliferation and sensitivity to epidermal growth factor receptor inhibitors.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 4, p. 915, doi. 10.1002/cncr.27785
- By:
- Publication type:
- Article
Retinoic acid induces REST degradation and neuronal differentiation by modulating the expression of SCF(β-TRCP) in neuroblastoma cells.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Retinoic acid induces REST degradation and neuronal differentiation by modulating the expression of SCF<sup>β-TRCP</sup> in neuroblastoma cells.
- Published in:
- Cancer (0008543X), 2011, v. 117, n. 22, p. 5189, doi. 10.1002/cncr.26145
- By:
- Publication type:
- Article
The selective Trk inhibitor AZ623 inhibits brain-derived neurotrophic factor-mediated neuroblastoma cell proliferation and signaling and is synergistic with topotecan.
- Published in:
- Cancer (0008543X), 2011, v. 117, n. 6, p. 1321, doi. 10.1002/cncr.25674
- By:
- Publication type:
- Article
Signaling of ERBB receptor tyrosine kinases promotes neuroblastoma growth in vitro and in vivo.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Signaling of ERBB Receptor Tyrosine Kinase Promotes Neuroblastoma Growth In Vitro and In Vivo.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 13, p. 3233, doi. 10.1002/cncr.25073
- By:
- Publication type:
- Article
A novel therapeutic combination for neuroblastoma: the vascular endothelial growth factor receptor/epidermal growth factor receptor/rearranged during transfection inhibitor vandetanib with 13-cis-retinoic acid.
- Published in:
- 2010
- By:
- Publication type:
- journal article
A Novel Therapeutic Combination for Neuroblastoma.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 10, p. 2465, doi. 10.1002/cncr.25017
- By:
- Publication type:
- Article
Allele-specific expression reveals genes with recurrent cis-regulatory alterations in high-risk neuroblastoma.
- Published in:
- Genome Biology, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s13059-022-02640-y
- By:
- Publication type:
- Article
Allele-specific expression reveals genes with recurrent cis-regulatory alterations in high-risk neuroblastoma.
- Published in:
- Genome Biology, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s13059-022-02640-y
- By:
- Publication type:
- Article
Outcomes of the POG 9340/9341/9342 trials for children with high-risk neuroblastoma: A report from the Children's Oncology Group.
- Published in:
- Pediatric Blood & Cancer, 2008, v. 51, n. 6, p. 747, doi. 10.1002/pbc.21713
- By:
- Publication type:
- Article
Outcomes of a two-drug chemotherapy regimen for intraocular retinoblastoma.
- Published in:
- Pediatric Blood & Cancer, 2008, v. 50, n. 3, p. 567, doi. 10.1002/pbc.21301
- By:
- Publication type:
- Article
Integrins interact with focal adhesions through multiple distinct pathways.
- Published in:
- Journal of Cellular Physiology, 1999, v. 181, n. 1, p. 74, doi. 10.1002/(SICI)1097-4652(199910)181:1<74::AID-JCP8>3.0.CO;2-H
- By:
- Publication type:
- Article
Binimetinib inhibits MEK and is effective against neuroblastoma tumor cells with low NF1 expression.
- Published in:
- 2016
- By:
- Publication type:
- journal article
A phase II trial of nifurtimox combined with topotecan and cyclophosphamide for refractory or relapsed neuroblastoma and medulloblastoma.
- Published in:
- International Journal of Cancer, 2023, v. 153, n. 5, p. 1026, doi. 10.1002/ijc.34569
- By:
- Publication type:
- Article
A subset analysis of a phase II trial evaluating the use of DFMO as maintenance therapy for high‐risk neuroblastoma.
- Published in:
- International Journal of Cancer, 2020, v. 147, n. 11, p. 3152, doi. 10.1002/ijc.33044
- By:
- Publication type:
- Article
Treatment of recurrent diffuse intrinsic pontine glioma: the MD Anderson Cancer Center experience.
- Published in:
- Journal of Neuro-Oncology, 2012, v. 106, n. 2, p. 391, doi. 10.1007/s11060-011-0677-3
- By:
- Publication type:
- Article
mTOR ATP-competitive inhibitor INK128 inhibits neuroblastoma growth via blocking mTORC signaling.
- Published in:
- Apoptosis, 2015, v. 20, n. 1, p. 50, doi. 10.1007/s10495-014-1066-0
- By:
- Publication type:
- Article
MEDU-41. TARGETING GRANULOCYTE COLONY STIMULATION FACTOR RECEPTOR EXPRESSING MEDULLOBLASTOMA CELLS.
- Published in:
- Neuro-Oncology, 2019, v. 21, p. ii112, doi. 10.1093/neuonc/noz036.199
- By:
- Publication type:
- Article